FROM NEUTRON TO PATIENT Trademark

Trademark Overview


On Tuesday, October 12, 2021, a trademark application was filed for FROM NEUTRON TO PATIENT with the United States Patent and Trademark Office. The USPTO has given the FROM NEUTRON TO PATIENT trademark a serial number of 97069693. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, April 3, 2024. This trademark is owned by POINT Biopharma USA Inc.. The FROM NEUTRON TO PATIENT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Pharmaceutical research and development services; providing medical research information in the fields of pharmaceuticals, oncology and nuclear medicine
from neutron to patient

General Information


Serial Number97069693
Word MarkFROM NEUTRON TO PATIENT
Filing DateTuesday, October 12, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, April 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Goods and ServicesPharmaceutical research and development services; providing medical research information in the fields of pharmaceuticals, oncology and nuclear medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePOINT Biopharma USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46268

Party NamePOINT Biopharma USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46268

Trademark Events


Event DateEvent Description
Tuesday, June 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 15, 2021NEW APPLICATION ENTERED
Tuesday, November 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 18, 2022ASSIGNED TO EXAMINER
Friday, July 22, 2022NON-FINAL ACTION WRITTEN
Friday, July 22, 2022NON-FINAL ACTION E-MAILED
Friday, July 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 25, 2023SOU EXTENSION 1 FILED
Wednesday, October 25, 2023SOU EXTENSION 1 GRANTED
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 3, 2024SOU EXTENSION 2 FILED
Wednesday, April 3, 2024SOU EXTENSION 2 GRANTED
Thursday, April 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED